Treatment of Thalassemia Major by Ayurveda

Management of Beejadushtijanya Pandu(Thalassemia Major)With Modified Musta-Triphaladi Avaleha and Gandhakadi Yoga-an Open labelled Randomized Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008174

Enrollment

Registered

2017-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed cases of Thalassemia Major

Interventions

Intervention1: Group A Modified Musta triphaladi Avaleha and Gandhakadi yoga with modern medical management: Diagnosed case of thalassemia major duration of treatment 12 weeks follow up 12 weeks .Drug

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Thalassemia Major

Exclusion criteria

Exclusion criteria: Children below 01 year and above 10 years of age Patients having HIV HBV infection hepatic failure DM TB etc Patient having BT interval for less than 12 days Patient undergone splenectomy

Design outcomes

Primary

Measure	Time frame
Establish an adjuvant therapy from ayurveda in order to 1 Prolonging the BT interval 2 Decrease the serum ferritin level 3 Enhance the life span of the thalassemic children 4 Increase the QOL of thalassemic patients 5 Minimise complication such as iron overloading pain etc Timepoint: Special investigations will be carried out before and after treatment for duration of 6 months	—

Secondary

Measure	Time frame
Enhance the life span of the thalassemic children Increase the QOL of thalassemic patients Timepoint: 18 months	—

Countries

India

Contacts

Public ContactDr V K Kori

Department of Kaumarbhritya IPGT and RA GAU JAMNAGAR

drkspatel2007@yahoo.co.in9427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026